Product Releases

Immunoassay and Cellular Pathway Mapping Kits

Thu, 12/10/2009 - 5:22am

PerkinElmer announced the expansion of its "No Wash" ALPHA (Amplified Luminescent Proximity Homogeneous Assay) Technology portfolio by introducing 46 new highly sensitive cell signaling pathway and biomarker research assay kits. The new assays provide researchers with comprehensive tools for advancing studies in cancer, inflammatory, and neurodegenerative disorders. PerkinElmer's AlphaScreen SureFire assays enable researchers to save time by providing the ability to study key biological pathways using the same sample and conditions in a single experiment. In addition, the kits simplify complex protocols, increasing the ability to automate high-throughput screening processes and assisting researchers in the transition from time-consuming Western Blot or ELISA methods. In addition, the Company's AlphaLISA "No Wash" immunoassay kits enable the study of biomarkers for multiple disease states. The latest assays include human and mouse biomarker targets, significantly broadening the applicability of the ELISA-alternative ALPHA technology portfolio. The 46 new offerings include 22 AlphaScreen(R)SureFire and 24 AlphaLISA "No Wash" immunoassay kits, bringing the combined number of ALPHA-based kits to 142 assays (66 AlphaScreen SureFire and 76 AlphaLISA assays). PerkinElmer, Inc., 800-762-4000,


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.